Associated Papers
Evaluation of non-canonical p53 functions in DNA replication and recombination for variant classification.
Jansche R et al.
Cell Death & Disease, 2026
Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenografts.
Òdena A et al.
Npj Precision Oncology, 2025
41272064 (PubMed )
Supplement: 41698_2025_1172_MOESM1_ESM.pdf
Single cell multi-omics reveal intra-cell-line heterogeneity across human cancer cell lines.
Zhu Q et al.
Nature Communications, 2023
38071219 (PubMed )
Supplement: 41467_2023_43991_MOESM2_ESM.pdf
TP53 germline pathogenic variants in modern humans were likely originated during recent human history.
Kou SH et al.
Nar Cancer, 2023
37304756 (PubMed )
Supplement: zcad025_supplemental_files.zip › Supplementary_Table_2.xlsx › PVs
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Palafox M et al.
Nature Communications, 2022
36071033 (PubMed )
Supplement: 41467_2022_32828_MOESM4_ESM.xlsx › Fig_2A_and_Table_S4
Targeted next generation sequencing of circulating tumor DNA provides prognostic information for management in breast cancer patients.
Shim H et al.
Annals of Translational Medicine, 2022
Proteasome Inhibition Overcomes ALK-TKI Resistance in ALK-Rearranged/TP53-Mutant NSCLC via Noxa Expression.
Tanimoto A et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2021
33310890 (PubMed )
Supplement: 10780432ccr202853-sup-247837_2_supp_6752777_qkgmhg.xlsx › Table_S1
Identification of relevant genetic alterations in cancer using topological data analysis.
Rabadán R et al.
Nature Communications, 2020
32732999 (PubMed )
Supplement: 41467_2020_17659_MOESM3_ESM.xls › TableS1
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Bolli N et al.
Leukemia, 2018
29789651 (PubMed )
Supplement: 41375_2018_37_MOESM14_ESM.xlsx › supp_Table1
Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance.
Suenaga M et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2018
Mutations driving CLL and their evolution in progression and relapse.
Landau DA et al.
Nature, 2015
26466571 (PubMed )
Supplement: NIHMS715090-supplement-Supplementary_Table_10.xlsx › deep_seq_evolving_clone_TP1
XMAn: a Homo sapiens mutated-peptide database for the MS analysis of cancerous cell states.
Yang X et al.
Journal of Proteome Research, 2014
Patterns and Biologic Features of p53 Mutation Types in Korean Breast Cancer Patients.
Kim HW et al.
Journal of Breast Cancer, 2014
Select a paper to view details